News

Ideas That Generate Results

In UAE, unhealthy eating habits as well as sedentary lifestyle of people are resulting in the increasing incidence of obesity. This, in turn, is resulting in the increasing prevalence of diabetes in the country, which is expected to further augment by 2-3% in next 3 to 4 years. With this increase, the condition will get more intense, thereby fuelling the demand of advanced medication like insulin in the country. According to our new research called "Diabetes Market in UAE", the insulin market in UAE is anticipated to grow at a CAGR of nearly 8% during 2010-2012.

In our analysis, we have acknowledged several critical trends prevailing in the diabetes care market in the UAE, which are determining the industry's current and future directions. As discussed in the report, growth in insulin sales in the country is largely associated with the increase in prevalence of type I diabetes. It is anticipated that there will be a high growth in the prevalence of type I diabetes, and this will propel the demand of insulin in the country.

The report also studies and identifies several initiatives that have been taken by the government in order to control the prevalence of diseases in the country. The report further states that these steps are not just enough and a lot more needs to be done. Also, there is a need to increase the private sector participation in both preventing and curing diseases. For this, the report provides several recommendations useful from the perspective of both clients as well as government. 

RNCOS' "Diabetes Market in UAE" gives extensive research and in-depth analysis of the UAE diabetes market. It also provides information on the key competitors in the market. Overall, our research study provides valuable information to clients looking to venture into this market and helps them to devise strategies while going for an investment/partnership in the concerned market.

For more information visit: http://www.rncos.com/Report/IM247.htm